Login to Your Account



ZymoGenetics' Thrombin Gets FDA Nod as Topical Hemostat

By Donna Young


Friday, January 18, 2008
The FDA Thursday approved ZymoGenetics Inc.'s Recothrom Thrombin, the first and only recombinant, plasma-free thrombin for use as a topical hemostat. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription